Eun-Ju Lee

14PUBLICATIONS
44CO-AUTHORS
Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 19, 2026
Upregulation of ITM2A by p53 activation modulates p53 function through physical interaction.

|Jul 20, 2026
An empirically refined workflow for generating patient-derived organoids from epithelial ovarian cancer.

|Jul 29, 2025
Efficacy and Safety of Chemotherapy Combined with Hormonal Therapy in Heavily Pretreated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ELSA/KGOG3049): A Multicenter Pilot Study.

Kidong Kim, Chel Hun Choi, Sang-Yoon Park

|Jul 04, 2025
Human endogenous retrovirus-K envelope protein is aberrantly expressed in serous ovarian cancer and promotes chemosensitivity via NF-κB/P-glycoprotein pathway inhibition.

Que Thanh Thanh Nguyen, Soo-Gui Shin, Tra Tran Thu Nguyen

|Oct 25, 2024
Current peritonectomy practice during debulking surgery in patients with newly diagnosed advanced ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 4004).

Myeong-Seon Kim, Yoo-Young Lee, Soo Jin Park

|Oct 16, 2024
From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps.

Kyung-Jin Min, Nam Kyeong Kim, Jae-Yun Song

Pageof 3

Frequent Collaborators

3 joint publications

Mikyung Kim

3 joint publications

Myong Cheol Lim

3 joint publications

Junsoo Park

2 joint publications

Jeong-Won Lee